glp-1 agonist drugs Agonists - What is it? GLP-1: Genetic Variants Related to
Description
The retrospective matched cohort study involved 16,827 patients evaluated by neuro-ophthalmologists from 2017 to 2023
Mayendraraj A, Rosenkilde MM, Gasbjerg LS
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment
10.1016/j.jchf.2014.04.005 193 WrightD
This suggests that the hair loss is not strictly dose-dependent in a linear way but rather connected to the metabolic changes that all therapeutic doses trigger, including significant weight loss with tirzepatide
Promising drugs, ongoing challenges The researchers also acknowledged how quickly the GLP-1 field is evolving
